IPP Bureau
Venus Remedies join AMR alliance to combat global health threat
By IPP Bureau - February 07, 2022
The antimicrobial resistance alliance recently released its third Progress Report, reflecting on collective achievements from the life sciences industry
Rahul Guha to join Thyrocare Technologies as MD & CEO
By IPP Bureau - February 07, 2022
Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice
WHO Goodwill Ambassador calls for renewed focus on leprosy
By IPP Bureau - February 07, 2022
The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic
Redcliffe Labs appoints Abhay Singavi as Chief Business Officer
By IPP Bureau - February 07, 2022
Takes charge to lead business innovation, strategy, alliance & partnerships
Serum receives green light for Omicron variant vaccine
By IPP Bureau - February 07, 2022
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore
By IPP Bureau - February 05, 2022
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Sun Pharma Advanced Research Company Q3FY22 loss at Rs. 15.84 crore
By IPP Bureau - February 05, 2022
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
IOL Chemicals and Pharmaceuticals Q3FY22 PAT at Rs. 40.07 crore
By IPP Bureau - February 05, 2022
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
Dishman Carbogen Amcis Q3FY22 PAT at Rs. 35.38 crore
By IPP Bureau - February 05, 2022
Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021
Sanofi unveils new corporate brand and logo
By IPP Bureau - February 05, 2022
Sanofi unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019
Expert panel recommends Emergency Use Authorisation for Sputnik Light
By IPP Bureau - February 05, 2022
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Indian govt. places order for five crore doses of Corbevax
By IPP Bureau - February 05, 2022
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Lupin Q3FY22 PAT at Rs 545.52 cr.
By IPP Bureau - February 04, 2022
Lupin has reported consolidated financial results for the period ended December 31, 2021
Pfizer Q3FY22 PAT at Rs 143.91 crore
By IPP Bureau - February 04, 2022
The company has reported standalone financial results for the period ended December 31, 2021.
Sun Pharma demonstrates strong performance on all fronts: ICICI Direct
By IPP Bureau - February 04, 2022
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses